x

Search for a clinical trial

* (*) mandatory field

(APL-A-005-02) Phase I - II clinical and pharmacokinetic study of Aplidin (APL) as a 3-hour intravenous infusion every 2 weeks, in children with refractory or relapsed malignant tumours and leukaemia -Terminated -

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : Pharma mar sa
    • Phase : I - II
  • Principal investigator of clinical trial

  • Dr Birgit GEOERGER
  • Département de Cancérologie de l'enfant et de l'adolescent
  • CLCC Institut Gustave Roussy
  • 114 rue Edouard Vaillant
  • 94805 VILLEJUIF CEDEX
  • FRANCE
  • More information
  • Phone  : 33 (0)1 42 11 41 73
  • Fax  : -
  • Website
  • Contact secretary  :
  • Sponsor of clinical trial

  • PHARMA MAR SA
  • Pharma Mar S.A.
  • PharmaMar S.A.
  • Avenida de los Reyes, 1. Polígono Industrial La Mina-Norte
  • 28770 COLMENAR VIEJO
  • SPAIN
  • More information
  • Phone  : 349 18 46 60 00
  • Fax  : 349 18 46 60 01
  • Website
  • Contact secretary  :
Last update: May 2009

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.